Virtuos Lyograft is a first-of-its-kind shelf-stable and complete autograft substitute that is in a ready-to-use, moldable state at room temperature. Credit: Orthofix Medical Inc / Business Wire.

Orthofix Medical has announced the limited commercial release and first patient implant of its Virtuos Lyograft.

Virtuos Lyograft is a first-of-its-kind shelf-stable and complete autograft substitute that has been developed for spine and orthopaedic procedures.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

MTF Biologics prepares the allograft using a proprietary process that maintains all the biologic components necessary for bone healing in the graft.

Virtuos provides hospitals with significant logistical and economic benefits, along with enhanced storage, shipping and operating room efficiency.

Orthofix stated that Virtuos is delivered in a ready-to-use, moldable state at room temperature.

The device can be delivered and stored at room temperature, eliminating the need for large amounts of dry ice, Styrofoam containers and freezer storage.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This enables flexible shipping choices and reduced packaging, with the aim of lowering carbon emissions.

Orthofix Global Spine president Kevin Kenny said: “The Virtuos Lyograft, provided through our exclusive partnership with MTF Biologics, is at the forefront of allograft technology.

“Processed through a proprietary preservation method, Virtuos provides the best of both worlds.

“It delivers a high-quality shelf-stable bone graft with the clinical performance and superior handling that clinicians desire, as well as streamlined logistics for storage and preparation for the hospital.”

The company stated that Virtuos Lyograft is a complementary addition to its broad line of biologics offered through its collaboration with MTF Biologics.

The line includes the FiberFuse Strip allografts, Legacy DBM, Trinity Evolution, Trinity Elite, FiberFuse Advanced and AlloQuent structural allograft.

Orthofix also markets and sells the Opus osteoconductive matrix, Opus BA bioactive bone graft, O-Genesis graft delivery system and Opus Mg Set bone void filler.

In February, the company introduced Opus BA, a synthetic bioactive bone graft solution developed for cervical and lumbar spine fusion procedures.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact